RT Journal Article
SR Electronic
T1 Evaluation of Nowcasting for Real-Time COVID-19 Tracking — New York City, March–May 2020
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.18.20209189
DO 10.1101/2020.10.18.20209189
A1 Greene, Sharon K.
A1 McGough, Sarah F.
A1 Culp, Gretchen M.
A1 Graf, Laura E.
A1 Lipsitch, Marc
A1 Menzies, Nicolas A.
A1 Kahn, Rebecca
YR 2020
UL http://medrxiv.org/content/early/2020/10/20/2020.10.18.20209189.abstract
AB To account for delays between specimen collection and report, the New York City Department of Health and Mental Hygiene used a time-correlated Bayesian nowcasting approach to support real-time COVID-19 situational awareness. We retrospectively evaluated nowcasting performance for case counts among residents diagnosed during March–May 2020, a period when the median reporting delay was 2 days. Nowcasts with a 2-week moving window and a negative binomial distribution had lower mean absolute error, lower relative root mean square error, and higher 95% prediction interval coverage than nowcasts conducted with a 3-week moving window or with a Poisson distribution. Nowcasts conducted toward the end of the week outperformed nowcasts performed earlier in the week, given fewer patients diagnosed on weekends and lack of day-of-week adjustments. When estimating case counts for weekdays only, metrics were similar across days the nowcasts were conducted, with Mondays having the lowest mean absolute error, of 183 cases in the context of an average daily weekday case count of 2,914. Nowcasting ensured that recent decreases in observed case counts were not overinterpreted as true declines and supported health department leadership in anticipating the magnitude and timing of hospitalizations and deaths and allocating resources geographically.Competing Interest StatementThe authors have declared no competing interest.Funding StatementS.K.G. was supported by the Public Health Emergency Preparedness Cooperative Agreement (grant NU90TP922035-01), funded by the U.S. Centers for Disease Control and Prevention. R.K. was supported by Award Number U54GM088558 from the U.S. National Institute of General Medical Sciences. M.L. was supported by the Morris-Singer Fund and a subcontract from Carnegie Mellon University under U.S. Centers for Disease Control and Prevention Award U01IP001121. This article's contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention, the National Institutes of Health, or the Department of Health and Human Services.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This work was reviewed and deemed public health surveillance that is non-research by the New York City Department of Health and Mental Hygiene Institutional Review Board.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesLine-level data, as required for nowcasting using the NobBS R package, are not publicly available in accordance with patient confidentiality and privacy laws. Publicly available data are linked below. https://www1.nyc.gov/site/doh/covid/covid-19-data.page